Health News

Ambit Announces Participation At 12th Annual BIO Investor Forum

Author: Australian Business

SAN DIEGO, Oct. 2, 2013 /PRNewswire/ -- Ambit Biosciences (Nasdaq: AMBI), a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced the Company's participation at the 12th Annual......

More...

More Articles...

PDL BioPharma Provides $60 Million in Financing to LENSAR
US and European Regulators Accept for Review OMS302 Marketing Applications
El NHS de Inglaterra designa a SIRT (radioterapia interna selectiva) como el primer tratamiento disponible a través de la nueva iniciativa "Commissioning through Evaluation"
Expatriates Could be Paying Too Much For International Private Medical Insurance
NHS England torna a SIRT (Radioterapia Seletiva Interna) o primeiro tratamento disponível através da nova iniciativa de comissionamento por avaliação
KLOX Technologies annonce l'approbation au Canada de son traitement novateur contre l'acné simple
Nutranomics Receives Purchase Order from GNC Franchise Owners in the Philippines
VG Life Sciences, Inc. Closes on $2,235,000 from Private Fund
Americans View Walking as Good for Health But Many Aren't Walking Enough to Realize Health Benefits: Survey
Improving The Self-Esteem Of The World

Page 1263 of 1908